Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Operating Expenses (2016 - 2023)

Historic Operating Expenses for RedHill Biopharma (RDHL) over the last 12 years, with Q2 2023 value amounting to $4.8 million.

  • RedHill Biopharma's Operating Expenses fell 4819.75% to $4.8 million in Q2 2023 from the same period last year, while for Dec 2024 it was $4.8 million, marking a year-over-year decrease of 7520.6%. This contributed to the annual value of $11.7 million for FY2024, which is 4458.76% down from last year.
  • Latest data reveals that RedHill Biopharma reported Operating Expenses of $4.8 million as of Q2 2023, which was down 4819.75% from $6.9 million recorded in Q1 2023.
  • In the past 5 years, RedHill Biopharma's Operating Expenses ranged from a high of $20.6 million in Q2 2021 and a low of $4.8 million during Q2 2023
  • Over the past 5 years, RedHill Biopharma's median Operating Expenses value was $9.2 million (recorded in 2020), while the average stood at $10.0 million.
  • Per our database at Business Quant, RedHill Biopharma's Operating Expenses soared by 12237.48% in 2021 and then plummeted by 5507.95% in 2022.
  • Quarter analysis of 5 years shows RedHill Biopharma's Operating Expenses stood at $6.4 million in 2019, then surged by 112.48% to $13.6 million in 2020, then dropped by 8.43% to $12.5 million in 2021, then crashed by 38.78% to $7.6 million in 2022, then crashed by 37.31% to $4.8 million in 2023.
  • Its last three reported values are $4.8 million in Q2 2023, $6.9 million for Q1 2023, and $7.6 million during Q4 2022.